<?xml version="1.0" encoding="UTF-8"?><xml><records><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Pantos, C.</style></author><author><style face="normal" font="default" size="100%">Paizis, I</style></author><author><style face="normal" font="default" size="100%">Mourouzis, I.</style></author><author><style face="normal" font="default" size="100%">Moraitis, P</style></author><author><style face="normal" font="default" size="100%">Tzeis, S</style></author><author><style face="normal" font="default" size="100%">Karamanoli, E</style></author><author><style face="normal" font="default" size="100%">Mourouzis, C</style></author><author><style face="normal" font="default" size="100%">Karageorgiou, H</style></author><author><style face="normal" font="default" size="100%">Cokkinos, D.V.</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Blockade of angiotensin II type 1 receptor diminishes cardiac hypertrophy, but does not abolish thyroxin-induced preconditioning</style></title><secondary-title><style face="normal" font="default" size="100%">Hormone and metabolic research</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2005</style></year></dates><number><style face="normal" font="default" size="100%">08</style></number><publisher><style face="normal" font="default" size="100%">{\copyright} Georg Thieme Verlag KG Stuttgart· New York</style></publisher><volume><style face="normal" font="default" size="100%">37</style></volume><pages><style face="normal" font="default" size="100%">500–504</style></pages><language><style face="normal" font="default" size="100%">eng</style></language></record></records></xml>